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Prader-Willi syndrome (PWS) is the most common form of human syndromic
obesity resulting from the non-expression of paternal alleles within the PWS
region of chromosome 15q11-13.
1,2 During childhood, the syndrome is manifested
by diminished fetal activity, muscular hypotonia, mental retardation, short stature,
small hands and feet, and eventually obesity.
3 Although obesity itself is associated
with atherosclerosis, literature shows that atherosclerosis in PWS is more serious
and earlier in onset than in the general obese population. Premature coronary
artery atherosclerosis and sudden cardiac death was reported in a 3-year-old
young PWS male.
4 Moreover, the natural history of PWS demonstrates that most
adult PWS patients have diabetes, dyslipidemia, and cardiopulmonary dysfunc-
tions, which lead to disability and death within the first three decades of life.
5
Ghrelin is a 28-amino acid residue peptide predominantly produced by the
stomach. Ghrelin signals directly to the hypothalamic regulatory nuclei that
control energy homeostasis.
6,7 In general, fasting plasma ghrelin levels are lower
in obese subjects than in lean controls
8,9 and are elevated in patients with anorexia
nervosa.
10 Fasting increases the plasma level of ghrelin, which then decreases after
feeding.
11-13 However, grossly elevated plasma ghrelin levels have been demon-
strated in PWS adults
14 and children.
15-17 Interestingly, plasma ghrelin concentra-
tions are reported to be positively associated with carotid artery atherosclerosis in
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Purpose: Prader-Willi syndrome (PWS) is a genetic disorder characterized by childhood-onset obesity and
endocrine dysfunction that leads to cardiovascular disability. The objective of the study is to assess the relationship
between carotid intima-media thickness (IMT) and atherosclerotic risk factors. Materials and Methods: Twenty-
seven PWS children and 24 normal controls were enrolled. Correlations of IMT with atherosclerotic risk factors
were assessed. Results: IMTs in the PWS group did not differ from those in the controls (p = 0.172), although total
ghrelin levels were higher in the PWS children (p = 0.003). The multivariate analysis revealed positive correlations
between total ghrelin levels ( = 0.489, p = 0.046) and IMT in the PWS group and between body mass index-
standard deviation score (BMI-SDS) ( = 0.697, p = 0.005) and IMT in the controls. Conclusion: Considering the
positive correlation of IMT with total ghrelin levels and the high level of ghrelin in PWS children, a further study is
warranted to evaluate the role of elevated ghrelin on atherosclerosis for PWS.
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middle-aged males and appear to be a novel risk factor for
atherosclerosis.
18
Therefore, we hypothesized that elevated plasma ghrelin
levels may be one of the risk factors for atherosclerosis in
PWS children, which is assessed by carotid artery intima-
media thickness (IMT). An ultrasound measurement of the
carotid wall is a surrogate marker of generalized atheros-
clerosis that correlates with the coronary artery disease and
predicts future cardiovascular events in adults.
19,20 More-
over, previous observations suggest that the thickening of
arterial IMT occurs in children with hypercholesterolemia
as well as in children with type 1 diabetes.
21,22 Therefore,
IMT measurement can be a useful marker for future athero-
sclerosis even in children.
We measured common carotid artery IMT in children
with PWS and in normal control subjects adjusted for age,
sex, and body mass index (BMI), and assessed the cor-
relations of IMT with vascular risk factors including sex,
age, BMI-standard deviation score (BMI-SDS), high-
density lipoprotein cholesterol (HDL-C), low-density lipo-
protein cholesterol (LDL-C), C-reactive protein (CRP),
homeostasis model assessment for insulin resistance
(HOMA-IR), and total ghrelin.
Subjects
We studied twenty-seven children with PWS and 24 normal
control subjects. The groups were adjusted for age, sex,
and BMI. The clinical characteristics of the study subjects
are shown in Table 1.
The PWS subjects were recruited from the outpatient
clinic of the Department of Pediatrics, Samsung Medical
Center, Sungkyunkwan University, Seoul, Korea. The
inclusion criteria were as follows: age of 7-14 years, normo-
tensive, nonsmoker, and absence of any chronic disease.
Subjects with diabetes mellitus (i.e., fasting plasma glucose
> 126 mg/dL with a 2 hour oral glucose tolerance test
value of >200 mg/dL) were excluded. All of the PWS
patients were receiving growth hormones (Genotropin
®;
Pfizer, New York, NY, USA) in a dose of 1 mg/m
2/day
(median duration of the growth hormone (GH) treatment:
2.5 years, interquartile range: 2.1-2.9 years). None of the
controls were receiving GH therapy. And none of the sub-
jects were taking any other medication except GH. 
Tanner stage evaluations were systematically performed
in all the children. All of them were prepubertal, and their
clinical characteristics are presented in Table 1. The pur-
pose of the study was explained and a written study pro-
tocol was sent to all parents or guardians. For the PWS
children, informed consent was obtained from the parents
or guardians; for the controls, it was obtained from the
study participants as well as the parents or guardians.
Monetary compensation was not provided to the subjects.
The study design was reviewed and approved by the
Samsung Medical Center Institutional Review Board.
Carotid artery ultrasound
The carotid artery was examined with a 12- to 5-MHz
broadband linear transducer using an HDI 5000 (ATL,
Bothell, WA, USA). Longitudinal images directed through
the center of the artery were taken for each vessel. The
carotid IMT was defined as the maximal distance between
the interface of the lumen and the intima and the interface
between the media and the adventitia and was recorded at
MATERIALS AND METHODS
Table 1.Clinical Characteristics of the Study Subjects
PWS group (n = 27) Control  group (n = 24) p value
Age (yrs) 10 (8 - 14) 10 (8 - 13) 1.00
Male : Female   15 : 12 11 : 13 0.49
BMI (kg/m
2) 24.3 (19.9 - 30.1) 25.4 (23.5 - 28.6) 0.37
BMI-SDS 2.18 (1.31 - 3.74) 2.95 (2.22 - 3.65) 0.20
Body fat % 41.8 (39.7 - 50.6) 40.5 (37.6 - 43.7) 0.11
HOMA-IR 3.12 (2.37 - 5.06) 3.64 (2.69 - 4.83) 0.64
Cholesterol (mmol/L) 4.27 (3.94 - 4.92) 3.99 (3.66 - 4.74) 0.20
HDL-C (mmol/L) 1.53 (1.35 - 1.74) 1.28 (1.12 - 1.48) < 0.01*
LDL-C (mmol/L) 2.56 (2.31 - 3.11) 2.47 (2.16 - 3.04) 0.50
Triglyceride (mmol/L) 0.87 (0.69 - 1.46) 1.08 (0.79 - 1.80)        0.17
Total ghrelin (ng/mL) 2.92 (2.31 - 4.63) 1.97 (1.10 - 2.71)  < 0.01*
Intima-Medial Thickness (cm) 0.04 (0.04 - 0.05) 0.05 (0.04 - 0.05) 0.17
BMI, body mass index; BMI-SDS, body mass index-standard deviation score; HOMA-IR, homeostasis model assessment for insulin 
resistance; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol. 
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common carotid arteries and averaged for the left and right
sides. All diameters were measured during diastole in
order to avoid image blurring due to systolic arterial wall
motion and minimize the influence of blood pressure.
Laboratory analysis
The total plasma ghrelin levels were measured in duplicate
using a commercial ELISA kit (Phoenix Pharmaceuticals,
Belmont, CA, USA) and the samples were diluted ten
times and the concentrations were re-calculated thereafter:
the inter- and intra-assay coefficients of variance were less
than 10%, and according to the manufacturer, the lower
and upper detection limits for this assay were 40.6 pg/mL
and 2,595 pg/mL, respectively. The HOMA-IR was used
for calculating the insulin sensitivity index. The body fat
percentage of all children was assessed using Lunar Pro-
digy dual energy X-ray absorptiometry (DXA) (GE Lunar,
Madison, WI, USA).
Statistical analysis 
All values are expressed as the median and interquartile
ranges in the tables and as means ± SE in the figures. The
t-test was used when the data were normally distributed; in
other cases, the Mann-Whitney U test was used to compare
the other values between the PWS and control groups. In
univariate analysis, the correlations were determined using
Spearman’s correlation analysis because the samples were
not normally distributed. In addition, multivariate analysis
(Spearman’s partial correlation analysis) was performed to
reveal variables that are related to IMT independently. The
following variables were included in analysis: sex, age,
BMI-SDS, HDL, LDL, triglyceride (TG), CRP, HOMA-IR,
and total ghrelin. All statistical analyses were performed
using SAS version 9.13 (SAS Corp., Cary, NC, USA). p
values < 0.05 were considered statistically significant.
Clinical characteristics of the study subjects
Table 1 describes the clinical characteristics of the study
subjects. The PWS and control groups did not differ signi-
ficantly with respect to age or sex ratio, BMI, BMI-SDS,
body fat percentage, CRP, and HOMA-IR. However, the
levels of HDL cholesterol in the PWS group were higher
than those observed in the control group [1.53 mmol/L
(1.35-1.74) vs. 1.28 (1.12-1.48), p = 0.004]; the total
cholesterol, LDL, and triglyceride levels did not differ
between the two groups.
IMTs and total ghrelin levels in PWS and control groups
IMTs in children with PWS did not differ from those in the
control group [0.04 cm (0.04-0.05) vs. 0.05 (0.04-0.05), p =
0.172]. However, the total ghrelin levels were higher in the
PWS group compared with the control subjects [2.92
ng/mL (2.31-4.63) vs. 1.97 (1.10-2.71), p = 0.003]. There
was no significant difference between the IMTs of PWS
male and female subjects (p = 0.299). Similarly, IMTs in
the control males did not differ from those in the control
females (p= 0.595). 
Univariate analysis 
In univariate analysis, there were correlations of IMT with
age ( = 0.446, p= 0.019), HDL ( = -0.399, p= 0.038) and
TG ( = 0.638, p = 0.003) in PWS group and BMI-SDS (
= 0.516, p = 0.009) in controls (Table 2). However, be-
cause there was a strong positive correlation of IMT with
TG ( = 0.638, p = 0.003) and a negative tendency of
RESULTS
Table 2.Univariate Analysis of Correlation with Carotid Intima-Media Thickness
Parameter
PWS group  Control group
pvalue pvalue
Age 0.446 0.01* 0.127 0.55
Body fat % 0.165 0.40 0.290 0.17
BMI-SDS 0.044 0.82 0.516 < 0.01*
Cholesterol 0.362 0.06 0.043 0.84
HDL-C - 0.399  0.03* - 0.008 0.70
LDL-C 0.281 0.15 - 0.009 0.66
Triglyceride 0.638 < 0.01* 0.190 0.37
CRP 0.008 0.96 0.148 0.49
HOMA-IR 0.048 0.81 0.360 0.08
Ghrelin 0.157 0.43 - 0.166 0.44
BMI-SDS, body mass index-standard deviation score; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; 
CRP, C-reactive protein; HOMA-IR, homeostasis model assessment for insulin resistance. 
, Spearman correlation coefficient.
*p< 0.05.Su Jin Kim, et al.
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correlation of TG with ghrelin ( = - 0.222, p = 0.266), the
correlation between IMT and ghrelin may be obscured by
the relation with TG. Therefore, a multivariate analysis
was needed to evaluate the relationship between ghrelin
and IMT.
Multivariate analysis
Remarkably, in multivariate analysis, the results revealed
the positive correlation of IMT with total ghrelin levels (
= 0.489, p = 0.046) in the PWS group (Fig. 1A) and with
BMI-SDS ( = 0.697, p = 0.005) in the control group (Fig.
1B) (Table 3). However, IMT did not correlate with the
ghrelin levels in the control group ( = 0.381, p = 0.178).
The other variables were not significantly correlated with
IMT both in the PWS group and controls. 
PWS is a genetic disease that can be caused by deletion,
uniparental disomy of chromosome 15q11, or imprinting
defects.
1,2,23,24 Because this condition first becomes noticeable
through hypotonia and poor feeding during the neonatal or
infant stages of development, this disorder can be detected
at this stage using methylation-specific PCR diagnostic
tests. Although infants with PWS appear physically under-
developed during their early life, they are likely to become
obese before reaching school age unless appropriate nutri-
tional guidance and growth hormone treatment is initiated.
Natural course study showed that obesity results in type 2
diabetes and early cardiovascular compromise within the
first three decades of life.
5 It has been reported that PWS
subjects suffer from cardiopulmonary dysfunction, which
often lead to disability within the first 3 decades of life and
early death.
5 Diabetes and dyslipidemia, which resulted
from excessive obesity, have been blamed for this morbi-
dity and mortality. However, the reported mortality in
PWS is far beyond our expectations; thus, further efforts to
elucidate the risk factors for atherosclerosis, besides the
known ones, were warranted.
DISCUSSION
Fig. 1. Correlation of intima media thickness (IMT) with total ghrelin in the PWS group (A) and BMI-SDS in the controls (B). IMT was significantly positively correlated
with total ghrelin in the PWS group ( = 0.489, p= 0.046). and BMI-SDS in the controls ( = 0.697, p= 0.005). PWS, Prader-Willi syndrome; BMI-SDS, body mass index-
standard deviation score.
Table 3.Multivariate Analysis between Adjusted Covariate and Carotid Intima-Media Thickness
Parameter
PWS group  Control group
pvalue pvalue
Age 0.296 0.24 0.006 1.00
Sex - 0.118 0.65 - 0.28. 0.32
BMI-SDS - 0.007 0.77 0.697 < 0.01*
HDL-C 0.051 0.84 0.065 0.82
LDL-C 0.047 0.85 - 0.316 0.27
CRP - 0.153 0.55 - 0.286 0.32
HOMA-IR - 0.181 0.48 0.494 0.07
Ghrelin 0.489 0.04* 0.381 0.18
BMI-SDS, body mass index-standard deviation score; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; 
CRP, C-reactive protein; HOMA-IR, homeostasis model assessment for insulin resistance.
= Spearman partial correlation coefficient, adjusted by each factors. 
*p < 0.05.
ABOur results did not show that IMTs in children with
PWS differ from those in the controls at the age of 10. We
speculate that definite carotid intima-media thickening
occurs over this age because atherosclerosis is a long time
process. A future study will be needed in an adult PWS
population to understand the natural atherosclerotic
process in PWS. Although the thickening of the carotid
artery is not evident in PWS children at the median age of
10 years, our study demonstrates that in elevated levels of
plasma ghrelin in children with PWS, which have been
reported by our group and several other groups, correlate
with IMT of the carotid artery. These findings suggest that
these elevated ghrelin levels may be a potential risk factor
for carotid artery intima-media thickening in PWS, which
may lead to atherosclerosis and coronary artery disease
within the first three decades of life.
5 
We tried to figure out the reason why the correlation
between IMT and ghrelin was not obvious in univariate
analysis. In univariate analysis, the relation with TG might
obscure the correlation between IMT and ghrelin, because
there was a strong positive correlation of IMT with TG (
= 0.638, p = 0.003) and a negative tendency of correlation
of TG with ghrelin ( = - 0.222, p = 0.266). Eventually, a
multivariate analysis revealed a positive correlation bet-
ween ghrelin and IMT ( = 0.489, p= 0.046).
However, there were a high level of ghrelin and a posi-
tive correlation of IMT with the total ghrelin level in PWS
children, which is not observed in age-, sex-, and BMI-
adjusted controls. This finding may be interpreted as a
potential risk factor for carotid intima-media thickening in
PWS children. Therefore, considering the positive correla-
tion of IMT with total ghrelin levels and the high level of
ghrelin in PWS children, a vigorous effort to lower the
known risk factors of atherosclerosis is advocated for
patients of PWS in general, and even for the PWS children
who are not extremely obese. Previously we reported a
greater tendency for the up-regulation of ghrelin level in
lean rather than in obese PWS individuals and inverse
correlations were found between plasma ghrelin levels and
the following: age, BMI percentage of the ideal weight for
age, and BMI percentile in PWS children.
16
There are few reports that have studied the relationship
between plasma ghrelin levels and the risk of atheroscle-
rosis; there was a report demonstrating a positive associa-
tion between the mean IMT and the ghrelin concentration
in the analysis of middle-aged males before and after
adjustments for the traditional risk factors of atheros-
clerosis.
18 Their report and our current study are somewhat
unexpected since ghrelin levels have been reported to be
negatively associated with BMI. Moreover, obesity itself
has been a well-known risk factor for atherosclerosis.
25
Therefore, high levels of ghrelin should have been negati-
vely associated with atherosclerosis and accordingly ob-
served as decreased thickness of carotid IMT in this study.
However, our study revealed that an elevated level of ghrelin
is positively related with carotid IMT independently.
So far, the effect of ghrelin on the vascular system is some-
what controversial. Ghrelin has been reported to improve
endothelial dysfunction and increase endothelial nitric
oxide synthetase expression in GH-deficient rats and
associate with the attenuation of sympathetic nerve acti-
vity.
26 However, the vasoconstrictive effects of ghrelin,
which adversely affect the vascular system, have also been
reported.
27
Our study is also limited because PWS subjects of this
study were treated with GH for 2.5 median years. But
Choe, et al.
17  have mentioned that hyperghrelinemia cannot
be explained by the IGF-1 or GH deficiency and that
hyperghrelinemia is not related to GH deficiency state in
PWS patients, because hyperghrelinemia is present even
after GH replacement.
In summary, at the median age of 10, no difference was
observed between the PWS and control groups with
respect to IMT; moreover, none of the children displayed
plaques or eccentric thickening of the carotid artery. How-
ever, there was a high level of ghrelin and a positive cor-
relation of IMT with total ghrelin level in PWS children,
which is not observed in age-, sex-, and BMI-adjusted
controls. And considering the positive correlation of IMT
with total ghrelin levels and the high level of ghrelin in
PWS children, a further study will be needed to elucidate
the effect of elevated ghrelin levels on the atherosclerosis
in patients of PWS group.
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